Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Silvio Aime; Mohammed Al-Qahtani; Martin Behe; Guy Bormans; Giuseppe Carlucci; Jean N. DaSilva; Clemens Decristoforo; Adriano Duatti; Philip H. Elsinga; Klaus Kopka; Xiang Guo Li; Zhibo Liu; Robert H. Mach; Oskar Middel; Jan Passchier; Marianne Patt; Ivan Penuelas; Ana Rey; Peter J.H. Scott; Sergio Todde; Jun Toyohara; Danielle Vugts; Zhi Yang

doi:10.1186/s41181-021-00128-x

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Silvio Aime, Mohammed Al-Qahtani, Martin Behe, Guy Bormans, Giuseppe Carlucci, Jean N. DaSilva, Clemens Decristoforo, Adriano Duatti, Philip H. Elsinga, Klaus Kopka^*, Xiang Guo Li, Zhibo Liu, Robert H. Mach, Oskar Middel, Jan Passchier, Marianne Patt, Ivan Penuelas, Ana Rey, Peter J.H. Scott, Sergio ToddeJun Toyohara, Danielle Vugts, Zhi Yang

^*Corresponding author for this work

Radiology and nuclear medicine

Research output: Contribution to journal › Review article › Academic › peer-review

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Original language	English
Article number	13
Journal	EJNMMI radiopharmacy and chemistry
Volume	6
Issue number	1
DOIs	https://doi.org/10.1186/s41181-021-00128-x
Publication status	Published - Dec 2021

Access to Document

10.1186/s41181-021-00128-x

Cite this

Aime, S., Al-Qahtani, M., Behe, M., Bormans, G., Carlucci, G., DaSilva, J. N., Decristoforo, C., Duatti, A., Elsinga, P. H., Kopka, K., Li, X. G., Liu, Z., Mach, R. H., Middel, O., Passchier, J., Patt, M., Penuelas, I., Rey, A., Scott, P. J. H., ... Yang, Z. (2021). Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI radiopharmacy and chemistry, 6(1), [13]. https://doi.org/10.1186/s41181-021-00128-x

@article{9fb8bae0912c4e72b42aba2fb901907d,

title = "Highlight selection of radiochemistry and radiopharmacy developments by editorial board",

abstract = "Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.",

author = "Silvio Aime and Mohammed Al-Qahtani and Martin Behe and Guy Bormans and Giuseppe Carlucci and DaSilva, {Jean N.} and Clemens Decristoforo and Adriano Duatti and Elsinga, {Philip H.} and Klaus Kopka and Li, {Xiang Guo} and Zhibo Liu and Mach, {Robert H.} and Oskar Middel and Jan Passchier and Marianne Patt and Ivan Penuelas and Ana Rey and Scott, {Peter J.H.} and Sergio Todde and Jun Toyohara and Danielle Vugts and Zhi Yang",

note = "Funding Information: Financial support from EJNMMI Radiopharmacy and Chemistry to make this review article available for Open Access is gratefully acknowledged. Open Access funding enabled and organized by Projekt DEAL. Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = dec,

doi = "10.1186/s41181-021-00128-x",

language = "English",

volume = "6",

journal = "EJNMMI radiopharmacy and chemistry",

issn = "2365-421X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

Aime, S, Al-Qahtani, M, Behe, M, Bormans, G, Carlucci, G, DaSilva, JN, Decristoforo, C, Duatti, A, Elsinga, PH, Kopka, K, Li, XG, Liu, Z, Mach, RH, Middel, O, Passchier, J, Patt, M, Penuelas, I, Rey, A, Scott, PJH, Todde, S, Toyohara, J, Vugts, D & Yang, Z 2021, 'Highlight selection of radiochemistry and radiopharmacy developments by editorial board', EJNMMI radiopharmacy and chemistry, vol. 6, no. 1, 13. https://doi.org/10.1186/s41181-021-00128-x

TY - JOUR

T1 - Highlight selection of radiochemistry and radiopharmacy developments by editorial board

AU - Aime, Silvio

AU - Al-Qahtani, Mohammed

AU - Behe, Martin

AU - Bormans, Guy

AU - Carlucci, Giuseppe

AU - DaSilva, Jean N.

AU - Decristoforo, Clemens

AU - Duatti, Adriano

AU - Elsinga, Philip H.

AU - Kopka, Klaus

AU - Li, Xiang Guo

AU - Liu, Zhibo

AU - Mach, Robert H.

AU - Middel, Oskar

AU - Passchier, Jan

AU - Patt, Marianne

AU - Penuelas, Ivan

AU - Rey, Ana

AU - Scott, Peter J.H.

AU - Todde, Sergio

AU - Toyohara, Jun

AU - Vugts, Danielle

AU - Yang, Zhi

N1 - Funding Information: Financial support from EJNMMI Radiopharmacy and Chemistry to make this review article available for Open Access is gratefully acknowledged. Open Access funding enabled and organized by Projekt DEAL. Publisher Copyright: © 2021, The Author(s).

PY - 2021/12

Y1 - 2021/12

N2 - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

AB - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

UR - http://www.scopus.com/inward/record.url?scp=85102834231&partnerID=8YFLogxK

U2 - 10.1186/s41181-021-00128-x

DO - 10.1186/s41181-021-00128-x

M3 - Review article

C2 - 33738618

AN - SCOPUS:85102834231

SN - 2365-421X

VL - 6

JO - EJNMMI radiopharmacy and chemistry

JF - EJNMMI radiopharmacy and chemistry

IS - 1

M1 - 13

ER -

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Abstract

Access to Document

Other files and links

Cite this